• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Public Health . Mortality Surveillance for the COVID-19 Pandemic: Review of the Centers for Disease Control and Prevention's Multiple System S

tetano

Editor, Senior Moderator
Am J Public Health


. 2024 Jul 25:e1-e10.
doi: 10.2105/AJPH.2024.307743. Online ahead of print. Mortality Surveillance for the COVID-19 Pandemic: Review of the Centers for Disease Control and Prevention's Multiple System Strategy

Diba Khan[SUP] 1 [/SUP], Meeyoung Park[SUP] 1 [/SUP], Peter Grillo[SUP] 1 [/SUP], Lauren Rossen[SUP] 1 [/SUP], B Casey Lyons[SUP] 1 [/SUP], Sarah David[SUP] 1 [/SUP], Matthew D Ritchey[SUP] 1 [/SUP], Farida B Ahmad[SUP] 1 [/SUP], A D McNaghten[SUP] 1 [/SUP], Adi V Gundlapalli[SUP] 1 [/SUP], Amitabh B Suthar[SUP] 1 [/SUP]



Affiliations
Abstract

Mortality surveillance systems can have limitations, including reporting delays, incomplete reporting, missing data, and insufficient detail on important risk or sociodemographic factors that can impact the accuracy of estimates of current trends, disease severity, and related disparities across subpopulations. The Centers for Disease Control and Prevention used multiple data systems during the COVID-19 emergency response-line-level case‒death surveillance, aggregate death surveillance, and the National Vital Statistics System-to collectively provide more comprehensive and timely information on COVID-19‒associated mortality necessary for informed decisions. This article will review in detail the line-level, aggregate, and National Vital Statistics System surveillance systems and the purpose and use of each. This retrospective review of the hybrid surveillance systems strategy may serve as an example for adaptive informational approaches needed over the course of future public health emergencies. (Am J Public Health. Published online ahead of print July 25, 2024:e1-e10. https://doi.org/10.2105/AJPH.2024.307743).


 
Back
Top Bottom